Verition Fund Management’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.25M | Sell |
25,796
-58,354
| -69% | -$2.84M | 0.01% | 1716 |
|
|
2025
Q1 | $2.86M | Buy |
84,150
+37,020
| +79% | +$1.26M | 0.01% | 1034 |
|
|
2024
Q4 | $1.86M | Buy |
47,130
+34,661
| +278% | +$1.36M | 0.01% | 1204 |
|
|
2024
Q3 | $586K | Buy |
12,469
+1,491
| +14% | +$70K | ﹤0.01% | 1605 |
|
|
2024
Q2 | $593K | Sell |
10,978
-10,315
| -48% | -$557K | ﹤0.01% | 1383 |
|
|
2024
Q1 | $1.45M | Buy |
21,293
+18,023
| +551% | +$1.23M | 0.01% | 992 |
|
|
2023
Q4 | $205K | Sell |
3,270
-4,250
| -57% | -$266K | ﹤0.01% | 1589 |
|
|
2023
Q3 | $341K | Buy |
+7,520
| New | +$341K | ﹤0.01% | 1358 |
|
|
2023
Q2 | – | Sell |
-26,597
| Closed | -$1.2M | – | 1971 |
|
|
2023
Q1 | $1.2M | Buy |
26,597
+21,474
| +419% | +$971K | 0.02% | 795 |
|
|
2022
Q4 | $208K | Buy |
+5,123
| New | +$208K | ﹤0.01% | 1354 |
|
|
2022
Q2 | – | Sell |
-4,014
| Closed | -$252K | – | 2238 |
|
|
2022
Q1 | $252K | Buy |
+4,014
| New | +$252K | ﹤0.01% | 1480 |
|
|
2020
Q1 | – | Sell |
-3,926
| Closed | -$239K | – | 601 |
|
|
2019
Q4 | $239K | Buy |
+3,926
| New | +$239K | ﹤0.01% | 778 |
|